Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 8199  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
This article has been cited by
1Small molecule therapy for managing moderate to severe psoriatic arthritis
Luisa Costa,Antonio Del Puente,Rosario Peluso,Marco Tasso,Paolo Caso,Maria Sole Chimenti,Vincenzo Sabbatino,Nicolò Girolimetto,Carolina Benigno,Nicoletta Bertolini,Aurora Del Puente,Roberto Perricone,Raffaele Scarpa,Francesco Caso
Expert Opinion on Pharmacotherapy.2017;18(15)1557
[DOI]
2Proteogenomic analysis of psoriasis reveals discordant and concordant changes in mRNA and protein abundance
William R. Swindell,Henriette A. Remmer,Mrinal K. Sarkar,Xianying Xing,Drew H. Barnes,Liza Wolterink,John J. Voorhees,Rajan P. Nair,Andrew Johnston,James T. Elder,Johann E. Gudjonsson
Genome Medicine.2015;7(1)1557
[DOI]
3Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis
Antonios N. Gargalionis,Lina S. Malakou,Christos Adamopoulos,Christina Piperi,Irene Theohari,Marjan Nokhbehsaim,James Deschner,Georgios Kokkalis,Penelope Korkolopoulou,Evangelia Papadavid,Athanasios G. Papavassiliou,Efthimia K. Basdra
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2018;1864(10)3468
[DOI]
4Psoriatic Arthritis Under a Proteomic Spotlight: Application of Novel Technologies to Advance Diagnosis and Management
Aisha Q. Butt,Angela McArdle,David S. Gibson,Oliver FitzGerald,Stephen R. Pennington
Current Rheumatology Reports.2015;17(5)3468
[DOI]
5Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors
Gilles Ouvry,Laurence Clary,Loïc Tomas,Michèle Aurelly,Laetitia Bonnary,Emilie Borde,Claire Bouix-Peter,Laurent Chantalat,Claire Defoin-Platel,Sophie Deret,Mathieu Forissier,Craig S. Harris,Tatiana Isabet,Laurent Lamy,Anne-Pascale Luzy,Jonathan Pascau,Catherine Soulet,Alessandro Taddei,Nathalie Taquet,Etienne Thoreau,Emeric Varvier,Emmanuel Vial,Laurent F. Hennequin
ACS Medicinal Chemistry Letters.2019;10(11)1561
[DOI]
6IL-9, a local growth factor for synovial T cells in inflammatory arthritis
Smriti Kundu-Raychaudhuri,Christine Abria,Siba P. Raychaudhuri
Cytokine.2016;79(11)45
[DOI]
7Differential Roles of the mTOR-STAT3 Signaling in Dermal ?d T Cell Effector Function in Skin Inflammation
Yihua Cai,Feng Xue,Hui Qin,Na Liu,Xu Chen,Chris Fleming,Xiaoling Hu,Huang-ge Zhang,Jie Zheng,Jun Yan
SSRN Electronic Journal.2018;79(11)45
[DOI]
8Updated therapies for the management of psoriatic arthritis
Atrin Toussi,Natalia Maverakis,Stephanie T. Le,Soumajyoti Sarkar,Smriti K. Raychaudhuri,Siba P. Raychaudhuri
Clinical Immunology.2020;79(11)108536
[DOI]
9Differential Roles of the mTOR-STAT3 Signaling in Dermal ?d T Cell Effector Function in Skin Inflammation
Yihua Cai,Feng Xue,Hui Qin,Xu Chen,Na Liu,Chris Fleming,Xiaoling Hu,Huang-ge Zhang,Fuxiang Chen,Jie Zheng,Jun Yan
Cell Reports.2019;27(10)3034
[DOI]
10Cyanate Induces Oxidative Stress Injury and Abnormal Lipid Metabolism in Liver through Nrf2/HO-1
Ling Hu,Kuan Tian,Tao Zhang,Chun-Hua Fan,Peng Zhou,Di Zeng,Shuang Zhao,Li-Sha Li,Hendrea Shaniqua Smith,Jing Li,Jian-Hua Ran
Molecules.2019;24(18)3231
[DOI]
11The role of PI3K/AKT/FOXO signaling in psoriasis
Miao Zhang,Xiaoyan Zhang
Archives of Dermatological Research.2019;311(2)83
[DOI]
12The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?
Charles J Malemud
Future Medicinal Chemistry.2015;7(9)1137
[DOI]
13Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Andras Perl
Nature Reviews Rheumatology.2016;12(3)169
[DOI]
14Gene expression profiling reveals the role of RIG1 like receptor signaling in p53 dependent apoptosis induced by PUVA in keratinocytes
Shruti Chowdhari,Neeru Saini
Cellular Signalling.2016;28(1)25
[DOI]
15Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies
Siba P. Raychaudhuri,Reason Wilken,Andrea C. Sukhov,Smriti K. Raychaudhuri,Emanual Maverakis
Journal of Autoimmunity.2017;76(1)21
[DOI]
16Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation
Claudia Buerger,Nitesh Shirsath,Victoria Lang,Alina Berard,Sandra Diehl,Roland Kaufmann,Wolf-Henning Boehncke,Peter Wolf,Miroslav Blumenberg
PLOS ONE.2017;12(7)e0180853
[DOI]
17TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin
Arti B. Patel,Irene Tsilioni,Zuyi Weng,Theoharis C. Theoharides
Experimental Dermatology.2018;27(2)135
[DOI]
18MiR-125b-5p and miR-181b-5p inhibit keratinocyte proliferation in skin by targeting Akt3
Yunpeng Zheng,Bingjie Cai,Xuyang Li,Dongqin Li,Guangwen Yin
European Journal of Pharmacology.2019;862(2)172659
[DOI]
19Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor–Mediated mTOR Inhibition in Human Keratinocytes
Valerio Chiurchiù,Cinzia Rapino,Emanuela Talamonti,Alessandro Leuti,Mirko Lanuti,Audrey Gueniche,Roland Jourdain,Lionel Breton,Mauro Maccarrone
The Journal of Immunology.2016;197(9)3545
[DOI]
20Immune mediators and therapies for pruritus in atopic dermatitis and psoriasis
Sebastian Yu,Yanxi Li,Yan Zhou,Taylor Follansbee,Samuel T. Hwang
Journal of Cutaneous Immunology and Allergy.2019;2(1)4
[DOI]
21Dual mTOR Inhibition Is Required to Prevent TGF-ß-Mediated Fibrosis: Implications for Scleroderma
Anupam Mitra,Jesus I. Luna,Alina I. Marusina,Alexander Merleev,Smriti Kundu-Raychaudhuri,David Fiorentino,Siba P. Raychaudhuri,Emanual Maverakis
Journal of Investigative Dermatology.2015;135(11)2873
[DOI]
  Search 
  The Journal 
  The Association 
  Dermalinks  
  Book of Abstracts 
  Site Statistics 
  Addresses 
  My Preferences 
  Online Submission 

Submit Articles

Alerts